Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-17-003127
Filing Date
2017-11-13
Accepted
2017-11-13 16:06:56
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1720764.htm 10-Q 419173
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10554
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10268
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 8156
  Complete submission text file 0001178913-17-003127.txt   1991388

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atms-20170930.xml EX-101.INS 319194
6 XBRL TAXONOMY EXTENSION SCHEMA atms-20170930.xsd EX-101.SCH 24511
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20170930_cal.xml EX-101.CAL 26123
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20170930_def.xml EX-101.DEF 74093
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20170930_lab.xml EX-101.LAB 156585
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20170930_pre.xml EX-101.PRE 135980
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 171195879
SIC: 2890 Miscellaneous Chemical Products